ASND Ascendis Pharma A/S

252.73USD-1.26%Mkt Cap: 16.58B USDP/E: 17.55

Ascendis Pharma A/S, operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Europe, the United States, and internationally. The company offers SKYTROFA for …